TNF and inflammatory bowel disease: Di Sabatino et al. found evidence for enhanced in vivo 11-dehydro-thromboxane-dependent PLT activation and lipid peroxidation in IBD patients while demonstrating that anti-TNF-α therapy with infliximab down-regulates isoprostane generation and TX biosynthesis in vivo in responder IBD patients (26).